SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-06
👔
ROCKET PHARMACEUTICALS, INC.
@RCKT_InsiderForm 4 Filing: Dolsten Mikael Acquires (Grant) shares of $RCKT
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
ROCKET PHARMACEUTICALS, INC.
Ticker: $RCKT
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-18
Shares: 22,862
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Dolsten Mikael, holds the title of Director at ROCKET PHARMACEUTICALS, INC..
On 2026-06-18, the insider transacted 22,862 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Dolsten Mikael (Director) was granted $0 of $RCKT
Post-Transaction Position: 67,082 shares
SEC Accession No: 0001140361-26-027679 (CIK: 1437590)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.